14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
AVDL vs AMD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Avadel Pharmaceuticals plc Ordinary Share (AVDL) captures the overall head-to-head institutional edge over Advanced Micro Devices (AMD) on higher Unified Composite conviction (62.9/100 BUY vs. 62.6/100 BUY) after splitting the core matrix 5–5 (led by Valuation Multiples), while AMD wins 5–1 across the 6-pillar growth and valuation breakdown. AVDL trades at $21.64 (28.8x Forward P/E, 2.5% operating margin) versus AMD at $424.39 (24.1x Forward P/E, 17.8% operating margin).
Growth vs. Quality Trade-Off: AVDL earns the overall head-to-head edge with a stronger Unified Composite Score (62.9/100 BUY vs. AMD 62.6/100 BUY) and 0.14β · 2% Vol risk profile, whereas AMD leads top-line expansion (+44.7% YoY revenue growth, 0.47x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVDL vs AMD. Trailing 12-month operating profitability (AVDL 2.5% vs AMD 17.8%) and valuation multiples (AVDL 28.8x vs AMD 24.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Edge AI / Inference ChipsHardware-Agnostic ML CompilersInference Serving / Speculative DecodingKV-Cache / Attention Memory CompressionMixture-of-Experts / Sparse Models
Investor FAQ AVDL vs AMD Key Questions & Quantitative Answers
As of Nov 20, 2026, Avadel Pharmaceuticals plc Ordinary Share (AVDL) captures the overall head-to-head institutional edge over Advanced Micro Devices (AMD) on higher Unified Composite conviction (62.9/100 BUY vs. 62.6/100 BUY) after splitting the core matrix 5–5 (led by Valuation Multiples), while AMD wins 5–1 across the 6-pillar growth and valuation breakdown. AVDL trades at $21.64 (28.8x Forward P/E, 2.5% operating margin) versus AMD at $424.39 (24.1x Forward P/E, 17.8% operating margin). Growth vs. Quality Trade-Off: AVDL earns the overall head-to-head edge with a stronger Unified Composite Score (62.9/100 BUY vs. AMD 62.6/100 BUY) and 0.14β · 2% Vol risk profile, whereas AMD leads top-line expansion (+44.7% YoY revenue growth, 0.47x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
AMD leads the Growth & Scale pillar: AVDL posts +54.9% YoY revenue growth and +0.0% YoY earnings growth on $249M TTM revenue (94.9% gross margin, 2.5% operating margin), compared with AMD at +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin). On trailing 12-month operating scale, AVDL generates $249M in USD-normalized revenue versus $45.4B for AMD. In operating R&D and SG&A reinvestment, AVDL deploys N/A (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($17.4B) (7 disclosures) for AMD.
AVDL screens cheaper on headline valuation multiples. AVDL trades at 28.8x Forward P/E, 16.8x Trailing P/E, 0.07x PEG, and 8.5x EV/Revenue (1.1% EBITDA margin), whereas AMD trades at 24.1x Forward P/E, 104.5x Trailing P/E, 0.47x PEG, and 17.9x EV/Revenue (15.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AVDL (-0.3% ROE) versus AMD (12.0% ROE) capital efficiency.
In options market volatility and institutional positioning, AVDL carries 2.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 2% Vol realized risk). By comparison, AMD carries 87.2% implied volatility (11th %ile, Compressed (<25th %ile)), a 1.31x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.65β · 124% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.